Comparative Efficacy of Therapeutic Ultrasound and Neurodynamic Techniques for Carpal Tunnel Syndrome
Comparative Study Of Ultrasound and Neurodynamic Technique For Patients With Carpal Tunnel Syndrome in Mild And Moderate Stag
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized controlled trial compares the efficacy of therapeutic ultrasound alone, neurodynamic techniques alone, and combined therapeutic ultrasound and neurodynamic techniques in patients with mild to moderate carpal tunnel syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 26, 2025
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedAugust 4, 2026
July 1, 2026
8 months
July 29, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain Intensity
Measure Description: Measured using the unabbreviated Visual Analog Scale (VAS). This scale ranges from 0 to 10 cm, where 0 represents no pain and 10 represents the worst imaginable pain. Higher scores indicate a worse outcome (greater pain intensity).
Baseline and 6 weeks post-intervention
Symptom Severity
Measure Description: Assessed using the unabbreviated Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ-SSS). The scale ranges from 1 to 5, with higher scores indicating a worse outcome (more severe symptoms).
Baseline and 6 weeks post-intervention
Functional Status
Measure Description: Assessed using Boston Carpal Tunnel Questionnaire Functional Status Scale (BCTQ-FSS). The scale ranges from 1 to 5, with higher scores indicating a worse outcome (greater functional disability/impairment).
Baseline and 6 weeks post-intervention
Study Arms (3)
Therapeutic Ultrasound Group
EXPERIMENTALContinuous therapeutic ultrasound applied to the volar wrist at 1.5 W/cm² for 8 to 10 minutes per session, 3 times per week for 6 weeks.
Neurodynamic Techniques Group
EXPERIMENTALMedian nerve neurodynamic mobilization (progressing from sliders to tensioners), 3 sets of 10 repetitions, 3 times per week for 6 weeks.
Combined Therapy Group
EXPERIMENTALCombined application of therapeutic ultrasound followed by neurodynamic techniques in the same session, 3 times per week for 6 weeks.
Interventions
Median nerve neurodynamic mobilization (progressing from sliders to tensioners), 3 sets of 10 repetitions.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of mild to moderate carpal tunnel syndrome confirmed by electrophysiological testing.
- Age between 18 and 65 years.
- Presence of symptoms (pain, numbness, tingling) for at least 3 months.
You may not qualify if:
- History of previous carpal tunnel release surgery or wrist trauma.
- Corticosteroid injection into the wrist within the past 3 months.
- Cervical radiculopathy, polyneuropathy, or other upper extremity neurological disorders.
- Pregnancy or lactation.
- Contraindications to therapeutic ultrasound (e.g., active infection, metallic implants in the treatment area, malignant tumors).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- IBB Universitylead
- Al-Razi Universitycollaborator
Study Sites (1)
Ibb University
Ibb, nine, Yemen
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor and Head of the Department of Human Medicine
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 4, 2026
Study Start
February 25, 2025
Primary Completion
November 1, 2025
Study Completion
November 26, 2025
Last Updated
August 4, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Not applicable as there is no current plan to share individual participant data publicly.